baber/WOPTO huggingface dataset:
Patent AU-2021202291-A1 (AU)
Title: Fraud detection system in casino
Inventor: SHIGETA YASUSHI
IPC: G06Q50/10
Filed: 2021-04-15
Abstract: A fraud detection system which detects fraud in a game 
of performing collection and redemption of chips in accordance 
with a win or lose result includes a camera which captures an 
image of chips contained in a chip tray of a dealer, an image 
analyzing apparatus which analyses the image captured by the 
camera to detect an amount of the chips contained in the chip 
tray, a card distribution device which determines a win or lose 
result of a game, and a control device which compares the win 
or lose result of the game and the amount of the chips contained 
in the chip tray before and after collection and redemption of 
the chips to detect fraud.
C14 
C14 
CIO 
Qc) 
CY) (C) 
(C) 
C14 
LU LO 
_5 E c) CY) IL Lu
CY) LU 
z 
03 
Qc) 
CI-4 r
00
Patent AU-2021209907-A1 (AU)
Title: Compositions and methods for cell-like calibration particles
Inventor: KIM JEFFREY
IPC: G01N21/00
Filed: 2021-01-22
Abstract: A method includes calibrating a cytometric device for analysis of a target cell, by inserting, into the cytometric device, a hydrogel particle. The hydrogel particle has at least one of a background fluorescent property or a spectral property that is substantially similar to the at least one of a background fluorescent property or a spectral property of the target cell. The method also includes measuring at least one property of the hydrogel particle using the cytometric device.
Patent AU-2021218962-A1 (AU)
Title: Recombinant nucleic acid construct and use thereof
Inventor: KAUFMANN JÖRG
IPC: C12N15/67
Filed: 2021-02-11
Abstract: The present invention is related to a recombinant nucleic acid construct comprising in 5'-> 3' direction - a 5' UTR, - a coding region coding for an effector molecule, and - a 3' UTR, wherein the 5' UTR is selected from the group consisting of a 5' UTR of a gene coding for MCP-1 or a derivative thereof having a nucleotide identity of at least 85 %, a 5' UTR of a gene coding for RPL12s.c. or a derivative thereof having a nucleotide identity of at least 85 %, a 5' UTR of a gene coding for Ang-2 or a derivative thereof having a nucleotide identity of at least 85 %, a 5' UTR of a gene coding for HSP70 or a derivative thereof having a nucleotide identity of at least 85 %, a 5' UTR of a gene coding for H3.3. or a derivative thereof having a nucleotide identity of at least 85 %, a 5' UTR of a gene coding for Galectin-9 or a derivative thereof having a nucleotide identity of at least 85 %, a 5' UTR of a gene coding for GADD34 or a derivative thereof having a nucleotide identity of at least 85 %, a 5' UTR of a gene coding for EDN1 or a derivative thereof having a nucleotide identity of at least 85 %, a 5' UTR of a gene coding for HSP70m5 or a derivative thereof having a nucleotide identity of at least 85 %, a 5' UTR of a gene coding for E-selectin or a derivative thereof having a nucleotide identity of at least 85 % a 5' UTR of a gene coding for ICAM-1 or a derivative thereof having a nucleotide identity of at least 85 %, a 5' UTR of a gene coding for IL-6 or a derivative thereof having a nucleotide identity of at least 85 % and a 5' UTR of a gene coding for vWF or a derivative thereof having a nucleotide identity of at least 85 %; wherein 3' UTR is selected from the group consisting of a 3' UTR of a gene coding for vWF or a derivative thereof having a nucleotide identity of at least 85 %, a 3' UTR of a gene coding for MCP-1 or a derivative thereof having a nucleotide identity of at least 85 %,, a 3' UTR of a gene coding for RPL12s.c. or a derivative thereof having a nucleotide identity of at least 85 %, a 3' UTR of a gene coding for HSP70 or a derivative thereof having a nucleotide identity of at least 85 %, a 3' UTR of a gene coding for H3.3. or a derivative thereof having a nucleotide identity of at least 85 %, a 3' UTR of a gene coding for GADD34 or a derivative thereof having a nucleotide identity of at least 85 %, a 3' UTR of a gene coding for EDN1 or a derivative thereof having a nucleotide identity of at least 85 %, and a 3' UTR of a gene coding for IL-6 or a derivative thereof having a nucleotide identity of at least 85 %, wherein the effector molecule is effective in restoring a cellular function of a cell or is effective in exercising a therapeutic effect in or on a cell, and wherein the recombinant nucleic acid construct is different from a wild type mRNA coding for the effector molecule.
Patent AU-2021231904-A1 (AU)
Title: Determining tissue characteristics using multiplexed immunofluorescence imaging
Inventor: SVEKOLKIN VIKTOR
IPC: G06T7/00
Filed: 2021-03-06
Abstract: Techniques for processing multiplexed immunofluorescence (MxIF) images. The techniques include: obtaining at least one MxIF image of a same tissue sample; obtaining information indicative of locations of cells in the at least one MxIF image; identifying multiple groups of cells in the at least one MxIF image at least in part by: determining feature values for at least some of the cells using the at least one MxIF image and the information indicative of locations of the at least some cells in the at least one MxIF image; and grouping the at least some of the cells into the multiple groups using the determined feature values; and determining at least one characteristic of the tissue sample using the multiple cell groups.
Patent AU-2021236681-A1 (AU)
Title: Rapid field-deployable detection of SARS-CoV-2 virus
Inventor: OTT MELANIE
IPC: G01N33/50
Filed: 2021-03-18
Abstract: The present disclosure relates to methods using CRISPR-Cas13 enzyme, complexed with SARS-CoV-2 crRNA guide RNAs to detect and quantify the presence of SARS-CoV-2 RNA in a sample with enhanced specificity and sensitivity. These methods can be used to diagnose SARS-CoV-2 infection, quantify the concentration of SARS-CoV-2 RNA present in a sample, identify the presence of different SARS-CoV-2 splice variants, subtypes, or mutations, and to monitor reactivation of SARS-CoV-2 transcription.
Patent AU-2021245770-A1 (AU)
Title: Appliance handle with automatic shutoff of input interface elements
Inventor: LEES HARRISON JOHN
IPC: F25D23/02
Filed: 2021-03-29
Abstract: An appliance having a cabinet, a door connected to the cabinet and movable in an opening direction from a closed position to an open position, and a handle connected to the door. The handle has a first side facing against the opening direction and forming a grasping surface, a second side facing along the opening direction, and an interface region having one or more input interfaces on the second side of the handle. The appliance has one or more shutoff sensors configured to disable at least one of the one or more input interfaces on the interface region when an object is detected adjacent the grasping surface.
Patent AU-2021248861-A1 (AU)
Title: Treating pulmonary inflammatory disease associated with COVID-19 by administering resiniferatoxin
Inventor: NAHAMA ALEXIS
IPC: A61K31/357
Filed: 2021-03-12
Abstract: There is disclosed a method for treating pulmonary inflammatory disease comprising administering an effective amount of resiniferatoxin (RTX) by an epidural, peri-ganglionic or intra-ganglionic administration. In some embodiments, the dose of RTX for an adult human is from about 0.1 µg to about 100 µg.
Patent AU-2021249117-A1 (AU)
Title: Flexible identity and access management pipeline
Inventor: DAWSON WILLIAM
IPC: H04L9/32
Filed: 2021-03-31
Abstract: A system and a method are disclosed for context-based policies for digital identity verification. A context-based identification system provides flexible identification procedures for various enterprises that adapted to the enterprises' services, the enterprises' customers, and these customers' needs. For example, the context-based identification system determines a first and second policy associated with a first enterprise and a third policy associated with a second enterprise. These policies include context parameters and verification parameters. The context-based identification system determines context parameters of a request, or "request context parameters," when a user requests to interact with the first enterprise and determines a policy with context parameters that substantially match these request context parameters. The context-based identification system may determine that the first policy's context parameters substantially match the request context parameters and use the first policy to verify the user's identity.
Patent AU-2021253674-A1 (AU)
Title: Ofatumumab for treating MS while maintaining serum IgG
Inventor: PINGILI RATNAKAR
IPC: A61K39/00
Filed: 2021-04-09
Abstract: The invention concerns ofatumumab for use in the treatment of multiple sclerosis (MS), wherein the treatment is a long-term treatment and wherein serum IgG level is maintained during the treatment. The invention further relates to B cell and/or T cell inhibitors for use in the treatment of MS, said treatment comprising monitoring serum IgG level and selecting ofatumumab as the B cell and/or T cell inhibitor if the serum IgG level decreases and/or said treatment comprising assessing the predisposition of the patient for an increased risk of infections and selecting ofatumumab as the B cell and/or T cell inhibitor if a predisposition is identified. The invention further relates to ofatumumab for use in the treatment of multiple sclerosis, wherein patients having a lowered serum IgG level are treated and/or wherein patients having risk factors associated with serum Ig levels, in particular serum IgG levels, are treated.
Patent AU-2021268311-A1 (AU)
Title: Vehicle capture assemblies and related devices, systems, and methods
Inventor: MICHEL MATTHEW ALAN
IPC: B64G1/64
Filed: 2021-03-21
Abstract: Vehicle capture assemblies and related devices, systems, and methods include one or more probe assemblies for engaging with and securing the target vehicle. The one or more probe assemblies may include one or more attenuation features or movable joints.
Patent AU-2021305330-A1 (AU)
Title: Water soluble prodrugs of PTBA for use in HDAC inhibition and enhancing renal recovery following acute kidney injury
Inventor: PLANTE JAMES
IPC: A61K31/165
Filed: 2021-07-08
Abstract: Novel compounds and compositions including the same and methods of manufacturing and using the same, particularly for inhibiting HDAC or HDAC activity, and more particularly for enhancing renal recovery following acute kidney injury (AKI), preferably through HDAC inhibition.
Patent AU-2021309601-A1 (AU)
Title: Wireless detonation system, relay device for wireless detonation system, and wireless detonation method using wireless detonation system
Inventor: UCHIDA Kohki
IPC: F42D1/00
Filed: 2021-07-12
Abstract: A wireless detonation system (1) has a blasting operation device (40), a detonator (10), and a relay device (30). The blasting operation device (40) is positioned at a distance from a work face (71) and transmits a first downlink wireless signal of a first frequency. The detonator (10) is loaded into a gunpowder charging hole (72) in the work face (71) and comprises a receiving coil (12) that receives a second downlink wireless signal of a second frequency lower than the first frequency. The relay device (30) comprises: a first transmitting-receiving antenna (35) that receives the first downlink wireless signal; a relay processor (32) that performs reception processing on the first downlink wireless signal and performs transmission processing with the second downlink wireless signal of the second frequency; and a second transmitting-receiving antenna (37) that transmits the second downlink wireless signal. The second transmitting-receiving antenna (37) is loaded into an insertion hole (74) in the work face (71) by the side of the gunpowder charging hole (72).
Patent AU-2021320485-A1 (AU)
Title: Systems and methods for screening
Inventor: HAWKINS ROBERT A
IPC: C02F1/38
Filed: 2021-08-09
Abstract: A screening system for solid removal includes a housing and a screen positioned within the housing. A flow inlet is operatively connected to an interior chamber defined by the screen. A sump is downstream from the flow inlet for capturing solids that do not pass through the screen. A flow outlet is downstream from the screen in fluid communication with the flow inlet. A moveable cleaning assembly may be positioned either within a perimeter of the screen, around the perimeter of the screen or both. The moveable cleaning assembly is moveable with respect to the screen.
Patent AU-2021324650-A1 (AU)
Title: Improved cupping device, system, and features
Inventor: BROWN CYNTHIA
IPC: A61H9/00
Filed: 2021-08-09
Abstract: A suction cup includes a body having a sidewall extending around an interior space and a rim extending around an opening to the interior space. At least a portion of the body is elastic and configured so that the body is capable of being squeezed to transition the body from an at- rest configuration to a partially-collapsed configuration, and elastically biased toward the at-rest configuration. The volume of the interior space of the body is greater in the at-rest configuration than in the partially-collapsed configuration. The rim is less stiff than a portion of the sidewall that is spaced apart from the rim. The relatively soft rim seeks to provide optimal adhesion to the skin of a user, fortification of another portion the body of the cup seeks to better maintain its shape for enhanced ease of use, and a vibration element can be included.
Patent AU-2021330948-A1 (AU)
Title: Mcl-1 inhibitor formulations
Inventor: HUCKLE JAMES E
IPC: A61K31/553
Filed: 2021-08-24
Abstract: Provided herein are solid dispersions comprising AMG 397, methods of preparing the solid dispersion, and pharmaceutical formulations comprising AMG 397.
Patent AU-2021358444-A1 (AU)
Title: Electrical power transmission
Inventor: SALEHI-MOGHADAM MANSOUR
IPC: H02H7/16
Filed: 2021-10-11
Abstract: A connection-and-protection device (108) for a power-transmission cable (104) having two capacitively connected conductors (105, 106) respectively connected in use to a supply cable (109) at one end and a load cable (110) at the other end is provided, the connection-and- protection device comprising: • a connection terminal (4) for connection to either of the supply or load cables, • a pair of cable terminals (5, 6) for the respective capacitively connected conductors (105, 106), • a direct connection (8) within the device between the connection terminal (4) and one of the pair of cable terminals (5), the other of the pair cable terminals (6) not normally being connected to the connection terminal (4) and • means (2) for connecting the other of the pair of cable terminals to the connection terminal to protect the capacitive connection of the two conductors, in the event that the voltage between the pair of cable terminals exceeds a threshold and • event detection means comprising means for detection the voltage between the pair of cable terminals (22) exceeding a threshold.
Patent AU-2021368118-A1 (AU)
Title: Compositions and methods for treating celiac sprue disease
Inventor: PULTZ INGRID
IPC: C12N9/50
Filed: 2021-10-29
Abstract: The present disclosure is directed to polypeptides capable of cleaving gluten proteins,
Patent AU-2021369679-A1 (AU)
Title: Dry powder compositions of treprostinil prodrugs and methods of use thereof
Inventor: DU JU
IPC: A61K31/216
Filed: 2021-10-28
Abstract: The present disclosure provides dry powder compositions of treprostinil prodrugs and methods of treating pulmonary hypertension (e.g., pulmonary arterial hypertension or PH associated with interstitial lung disease), in a patient in need thereof with the same. The dry powder composition includes (a) from about 0.5 wt% to about 5 wt% of a compound of a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, (b) from about 10 wt% to about 61 wt% of leucine, and the balance being (c) a sugar selected from the group consisting of trehalose and mannitol. The entirety of (a), (b), and (c) is 100 wt%, and R1 is tetradecyl, pentadecyl, hexadecyl, heptadecyl, or octadecyl. The method of treating PH includes administering an effective amount of the dry powder composition to the lungs of the patient by inhalation via a dry powder inhaler, during an administration period.
Patent AU-2021377952-A1 (AU)
Title: Crystal form of free base of inhibitor containing bicyclic ring derivative and preparation method and application of crystal form
Inventor: DONG HUA
IPC: A61K31/437
Filed: 2021-11-15
Abstract: The present invention relates to a crystal form of a free base of an inhibitor containing a bicyclic ring derivative and a preparation method and an application of the crystal form, and in particular to a crystal form of a compound represented by general formula (I), a preparation method and a pharmaceutical composition containing a therapeutically effective amount of the compound crystal form, and an application of the crystal form used as an RET inhibitor in treatment of diseases such as cancer, inflammation, chronic liver diseases, diabetes, cardiovascular diseases and AIDS.
Patent AU-2021378475-A1 (AU)
Title: Loop mediated isothermal nucleic acid amplification (lamp) using lna-modified primers and a metal-based colorimetric method for detecting an amplification product
Inventor: CEKAN PAVOL
IPC: C12Q1/6844
Filed: 2021-11-10
Abstract: The present invention relates to a loop mediated isothermal amplification (LAMP) method characterized in that the F3 nucleotide sequence and/or said B3 nucleotide sequence comprises one or more locked nucleic acid (LNA) nucleotides which are located within the first third of said F3 nucleotide sequence or said B3 nucleotide sequence, respectively. The present invention further relates to an in vitro method for detecting a nucleic acid sequence amplification product characterized by the use of a metallochromic indicator, preferably 5-Br-PAPS, and metal ions, preferably Zn
Patent AU-2021410998-A1 (AU)
Title: Modular system for treating effluent from cleaning hulls of floating units
Inventor: LIGEIRO BARBOSA MARCELO LUIZ
IPC: C02F1/00
Filed: 2021-12-20
Abstract: The present invention is a system for treating effluent from robotic equipment used to remove marine biofouling, primarily targeting organisms such as orange cup coral, which collect on hulls of floating units for transporting oil and derivatives thereof, or on production and exploration platforms. The system involves separating the flow into two elemental phases: solid and liquid. In the solid-phase flow, treatment is carried out in steps essentially comprising particle-size reduction, direct oxidation, oxidation residence, separation, drying, temporary hermetic storage, packaging, and automatic transportation for final storage. The liquid phase includes a step of centrifuging, adsorption, inerting, and discharge of treated effluent into the sea in accordance with environmental law. The entire system is automated to minimize manual actions and interventions, and is programmed to run without interruption as a function of the flow rate of raw effluent.
Patent AU-2021448036-A1 (AU)
Title: A system and a method for micronization of solid particles using valvular conduit
Inventor: HEGDE SHREEPAD
IPC: B02C19/06
Filed: 2021-09-15
Abstract: A system (100) for micronization of solid particles using valvular conduit comprises one or more compressed gas lines (1) (2) (3) provided with a respective compressed gas inlet (102); one or more powder feeders (104), each installed in a respective compressed gas lines (1) (2) (3); one or more valvular conduit modules (106), each made of a series of valves connected via a common passage, wherein each valvular conduit module (106) is connected downstream of the respective one or more powder feeders (104); a cyclonic separator (112) connected with all the respective compressed gas lines (1) (2) (3) connected with respective outlets of the respective one or more valvular conduit modules (106); and one or more particle size analysers in combination with one or more directional valves (108) disposed on the compressed gas lines (1) (2) (3) proximal to the outlets of the one or more valvular conduit modules (106).
Patent AU-2022200997-A1 (AU)
Title: An Accessory for Carrying Items on a Garment
Inventor: BITKOW EMILY
IPC: A45C1/00
Filed: 2022-02-15
Abstract: An accessory for carrying items on a garment includes a pouch and a securing flap. The item is 
carried in the pouch. The pouch is joined to the securing flap in a bifolding arrangement. The 
accessory includes one or more magnets along the pouch and the securing flap. The accessory 
has a flexible spine intermediate the pouch. The magnets magnetically attach the securing flap to 
the pouch when the pouch and the securing flap are folded together. The spine has a width 
defined between two parallel stitch lines. The pouch includes a slide fastener extending between 
lateral sides of the pouch for providing access to a pocket defined by the pouch. The pouch 
includes reflective material on an outside of the pouch. The pouch includes one or more internal 
pockets within the pocket of the pouch.
Patent AU-2022203074-A1 (AU)
Title: Multi-function three-stage pressure regulator
Inventor: CARTER STEPHEN A
IPC: B64C39/02
Filed: 2022-05-09
Abstract: A.04NPR] PATENT 
ABSTRACT 
An integrated pressure regulator is provided with three stages configured to reduce an 
extreme tank pressure down to a typical working pressure. The regulator is configured to supply 
a steady working pressure until the tank pressure is reduced to little more than the working 
pressureitself. Stages of thepressure regulator are integrated into abody and arranged to 
minimize regulator mass and volume. A thermally-triggered pressure relief device may be 
included with a triggering time adapted to enhance the safety of smaller cylinders that may be 
used, e.g., in aerial applications.  
36
-2 
100 - 208 
220 159 
137-
100 
FIG. 4 
28 -164 C22 
1221 
4 2142 
2152 
163a -50 
163b 150 
2225 142a 
163c28 
228
Patent AU-2022212954-A1 (AU)
Title: Systems, devices, and methods related to ketone sensors
Inventor: KARINKA SHRIDHARA
IPC: A61B5/145
Filed: 2022-01-26
Abstract: Systems are provided for an in vivo ketone sensor having a distal portion configured for placement in contact with an interstitial fluid of a user and a proximal portion including a working electrode, a sensing layer with P-hydroxybutyrate dehydrogenase, and a membrane layer configured to limit transport of one or more biomolecules. The in vivo ketone sensor is configured to generate signals at the working electrode corresponding to an amount of ketone in the interstitial fluid. Further, the systems includes a sensor control unit having at least one contact in electrical communication with the proximal portion of the sensor, which is configured to receive the generated signals, and convert the generated signals to ketone concentration data using a sensitivity associated with the in vivo ketone sensor. Also included is a transmitter configured to communicate ketone concentration data to a remote device.
Patent AU-2022214393-A1 (AU)
Title: Microwell assay plate and related methods
Inventor: KORPIMAKI TEEMU
IPC: G01N33/543
Filed: 2022-02-01
Abstract: A microplate comprising: a plurality of wells arranged in a two-dimensional array, each of the wells comprising: a bottom surface, sidewalls extending from the bottom surface to form an open top; and at least two subwells in the bottom surface, the at least two subwells having sidewalls that extend below the bottom surface of the well, wherein each of the at least two subwells comprises a capture binding agent that is configured to bind to a target analyte, if present, in a sample. A sample is added to the well such that the sample fluidically contacts each of the at least two subwells such that a target analyte, if present, binds to the capture binding agent in one or more of the at least two subwells, wherein a labeled conjugate (e.g., an upconverting nanoparticle (UCNP) labeled conjugate) in the sample binds with the target analyte, if present. A label (e.g., UCNP) of the labeled conjugate is detected at one or more of the at least two subwells to thereby determine whether the target analyte is present in the sample.